Compare ADIL & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADIL | AUST |
|---|---|---|
| Founded | 2010 | 2020 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4M | 13.3M |
| IPO Year | 2017 | 2021 |
| Metric | ADIL | AUST |
|---|---|---|
| Price | $3.22 | $0.80 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | ★ 39.2K | 20.7K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.87 |
| 52 Week High | $9.90 | $3.92 |
| Indicator | ADIL | AUST |
|---|---|---|
| Relative Strength Index (RSI) | 29.42 | 21.83 |
| Support Level | $2.38 | N/A |
| Resistance Level | $4.94 | $1.43 |
| Average True Range (ATR) | 0.42 | 0.06 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 1.86 | 23.66 |
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Austin Gold Corp is focused on the acquisition, exploration, and evaluation of mineral resource properties in the western United States of America (USA). The exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek, Lone Mountain, Stockade Mountain, Fourmile Basin, and Miller.